Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/75017

Registo completo
Campo DCValorIdioma
dc.contributor.authorZamboni, Fernandapor
dc.contributor.authorCengiz, Ibrahim F.por
dc.contributor.authorBarbosa, Ana M.por
dc.contributor.authorCastro, António G.por
dc.contributor.authorReis, R. L.por
dc.contributor.authorOliveira, Joaquim M.por
dc.contributor.authorCollins, Maurice N.por
dc.date.accessioned2021-12-20T12:22:16Z-
dc.date.available2021-12-20T12:22:16Z-
dc.date.issued2021-11-13-
dc.identifier.citationZamboni, F.; Cengiz, I.F.; Barbosa, A.M.; Castro, A.G.; Reis, R.L.; Oliveira, J.M.; Collins, M.N. Towards the Development of a Female Animal Model of T1DM Using Hyaluronic Acid Nanocoated Cell Transplantation: Refinements and Considerations for Future Protocols. Pharmaceutics 2021, 13, 1925. https://doi.org/10.3390/pharmaceutics13111925por
dc.identifier.urihttps://hdl.handle.net/1822/75017-
dc.descriptionSupplementary Materials: The following are available online at https://www.mdpi.com/article/10 .3390/pharmaceutics13111925/s1. Figure S1 (A) Intraperitoneal injection of STZ. (B) Mice are kept in cages with ad libitum fed regimen. Figure S2 MIN-6 cell transplantation. A) Abdominal viscera of female mice. (B) Intramuscular administration of anaesthetics. (C) Topical application of Vaseline to protect eyes from drying during surgery, lateral hair removal for incision. (D) Graft injection inside the kidney capsule. (E–F) Suture and stiches. (G) Post-operation recovery.por
dc.description.abstractFemale mice (Black 6 strain) (C57BL/6) aged 6 weeks were subject to low dose streptozotocin (STZ) treatment for five consecutive days to mimic type 1 diabetes mellitus (T1DM) with insulitis. At two weeks after STZ injections, evaluation of the elevated glucose levels was used to confirm diabetes. The diabetic mice were then subject to the transplantation of pancreatic β-cells (MIN-6 line). Four groups of mice were studied. The first group was injected with saline-only acting as the placebo surgery control, also known as SHAM group, the second and third groups were injected with MIN-6 single cells and polyethylene glycol-modified dipalmitoyl-glycerol-phosphatidyl ethanolamine (PEG-DPPE) modified MIN-6 single cells (500 µg per 1.10<sup>6</sup> cells), respectively, while the fourth group was injected with hyaluronic acid (HA)-coated MIN-6 single cells (5 bilayers). At seven- and fourteen-days following transplantation, the mice were euthanised. The renal and pancreatic tissues were then collected and histologically analysed. The induction of diabetes in female mice, through five-consecutive daily STZ injections resulted in inconsistent glycaemic levels. Interestingly, this shows an incomplete diabetes induction in female mice, of which we attribute to sex dimorphism and hormonal interferences. Transplantation failure of free-floating encapsulated cells was unable to decrease blood glucose hyperglycaemia to physiological ranges. The result is attributed to deprived cell–cell interactions, leading to decreased β-cells functionality. Overall, we highlight the necessity of refining T1DM disease models in female subjects when using multiple low-dose STZ injections together with transplantation protocols. Considerations need to be made regarding the different developmental stages of female mice and oestrogen load interfering with pancreatic β-cells susceptibility to STZ. The use of pseudo islets, cell aggregates and spheroids are sought to improve transplantation outcome in comparison to free-floating single cells.por
dc.description.sponsorshipIrish Research Council Postgraduate Scholarship (GOIPG/2015/3577) and ERASMUS+ grant student mobility placement (University of Limerick/Erasmus+ 1920) for F.Z. The authors also thank the financial support under the FRONTHERA (NORTE-01-0145-FEDER-000023) project (J.M.O. and I.F.C.), and the project 2IQBIONEURO (ref. 0624_2IQBIONEURO_6_E) (J.M.O. and I.F.C.), and TERM RES-Hub, Tissue Engineering and Regenerative Medicine Infrastructure project, funded by the Portuguese Foundation for Science and Technology (FCT) (I.F.C.).por
dc.language.isoengpor
dc.publisherMultidisciplinary Digital Publishing Institutepor
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectdiabetes inductionpor
dc.subjectfemale animal modelpor
dc.subjecttransplantationpor
dc.titleTowards the development of a female animal model of T1DM using hyaluronic acid nanocoated cell transplantation: refinements and considerations for future protocolspor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/13/11/1925por
oaire.citationIssue11por
oaire.citationVolume13por
dc.date.updated2021-11-25T16:01:37Z-
dc.identifier.eissn1999-4923-
dc.identifier.doi10.3390/pharmaceutics13111925por
dc.subject.fosCiências Médicas::Outras Ciências Médicaspor
dc.subject.wosScience & Technologypor
sdum.journalPharmaceuticspor
oaire.versionVoRpor
dc.relation.datasetinfo:eu-repo/semantics/dataset/doi/10 .3390/pharmaceutics13111925/s1por
Aparece nas coleções:3B’s - Artigos em revistas/Papers in scientific journals
ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
pharmaceutics-13-01925-v3.pdf6,06 MBAdobe PDFVer/Abrir

Este trabalho está licenciado sob uma Licença Creative Commons Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID